Overview

Lipid Biomarkers for Diabetic Heart Disease

Status:
Completed
Trial end date:
2018-02-23
Target enrollment:
Participant gender:
Summary
This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
Leducq Foundation
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health (NIH)
Treatments:
Fenofibrate